chrisvoncsefalvay/vaers-outcomes huggingface dataset:
20 minutes after I was vaccinated I went through an allergic reaction; itching; hives later in the day; very minor breathing  issues; semi lethargic state in functionality; safe to get a second vaccine as the response  was minor; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing  issues) and LETHARGY (semi lethargic state in functionality) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing  issues), LETHARGY (semi lethargic state in functionality) and PRODUCT DOSE OMISSION ISSUE (safe to get a second vaccine as the response  was minor). At the time of the report, HYPERSENSITIVITY (20 minutes after I was vaccinated I went through an allergic reaction), PRURITUS (itching), URTICARIA (hives later in the day), IRREGULAR BREATHING (very minor breathing  issues) and LETHARGY (semi lethargic state in functionality) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (safe to get a second vaccine as the response  was minor) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  No Treatment medications was provided.   Reporter did not allow further contact
neck pain; headache; joint inflammation in my knees and wrists; erethyma nodosum; muscle aches; upper back pain on the left side and body aches; upper back pain on the left side and body aches; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; my c reactive protein and sed rate levels which were high in the hospital, as well as my heart rate; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7533), via an unspecified route of administration, administered in Arm Left on 06Apr2021 11:00 as 1st dose, single for COVID-19 immunization. There were no medical history.  No COVID-19 prior to vaccination. Patient did not receive other vaccine within 4 weeks. Concomitant medication included vitamin D; ascorbic acid, zinc citrate (ZINC + VITAMIN C); and minocycline HCL all taken for an unspecified indication, start and stop date were not reported. On 16Apr2021 23:00, 10 days after the first dose, the patient started feeling upper back pain on the left side and body aches. On an unspecified date, over the course of the next few days, the patient had extreme neck pain and headache, as well as joint inflammation in knees and wrists as well as erythema nodosum. The patient went to the urgent care and was told to go to the ER to be evaluated for meningitis. The ER discharged the patient with a diagnosis of muscle aches. Over the course of a few more days, on an unspecified date, the symptoms worsened and patient checked into a different ER and was admitted to the hospital and the infectious disease doctor ran tests and told the patient that this was most likely a vaccine side effect. The patient had numerous tests done in the hospital and everything came back normal except for C-reactive protein and sedimentation rate levels which were high in the hospital, as well as the heart rate. They kept the patient in the hospital for 1 day overnight to monitor while administering dexamethasone and IV fluids which helped relieve the symptoms. The outcome of the events was reported as not recovered. The patient had COVID-19 PCR tests via nasal swab on 19Apr2021 and 22Apr2021 and both with negative result.
This case was considered medically important (OMIC). Information regarding Prevnar was received from a consumer regarding a 35 month old male patient who experienced pervasive developmental disorder. At 12 months of age, the patient received the fourth dose on 9/26/01. The patient's concurrent illness includes a food allergy. Indication for Prevnar was immunization. Product was administered on 9/26/01. Dose regimen was 1 dose (IM). Concomitant medications were not reported. The patient developed pervasive developmental disorder on 8/03. The outcome is unknown. No additional information was available at the time of the report.
had flu like symptoms for approximately 24 hours following time of the vaccine injections In December, i was diagnosed with cancer of the transverse colon during my annual colonoscopy.
could not sleep; Tightness in chest; Caller states she could not take a deep breath; slight allergic reaction/The allergic reaction itself is the carrier agent for the mRNA polyglycol; redness on arm; Akathisia; arm had soreness; nausea; This is a spontaneous report from a contactable consumer (patient). A 52-year-old (53-year-old was reported) female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 26May2021 (Batch/Lot Number: ER8730) as single dose for covid-19 immunisation at the age of 52-year-old. Medical history included hypothyroidism, does not know how long she has had, she takes t4 and t3 and is responsive with it; ongoing familial high cholesterol: she was 19 at like 300, asthma, overweight, allergic to polyglycol in scopolamine patches that was used for nausea. she does great with it, but the patch she gets a horrible red, weepy blister effect. she has had Akathisia with reglan or metoclopramide before, if she gets iv she just wants to rip it out and leave the room and get out. she does not use them anymore, that is why she has zofran and phenergan. The patient experienced tightness in chest on 26May2021, she could not take a deep breath on 26May2021, could not sleep on 27May2021, slight allergic reaction/the allergic reaction itself is the carrier agent for the mrna polyglycol in May2021, redness on arm where the needle went in in May2021, akathisia in May2021, arm had soreness in May2021, nausea in May2021. Outcome of all events was unknown. Therapeutic measures were taken as a result of tightness in chest, could not take a deep breath, nausea. The reporter states she had a side effect, she does not think an allergic reaction, but yeah it was a slight one. The allergic reaction itself is the carrier agent for the mRNA polyglycol which she believes is in scopolamine patches which she is allergic to.  This started off as that.  Within 20-30 minutes of getting the shot.  That one she did not like, but she understands it when she looked at the carrier agent.  Reporter states that scopolamine is used for nausea. The drug she does great with, but the patch she gets a horrible red, weepy blister effect.  Caller provides no additional details, she states that she no longer has the patches because they were all taken away and she does not use them anymore, now she uses zofran. The redness is where the needle went in. she got the shot wednesday, and that was when her chest tightness, she treated it thursday but it was getting better enough she needs steroids, she could not take a deep breath, she is experiencing this still. Today when she got up, she could not sleep last night, her first thought was it was insomnia. She is taking albuterol to open her airways. She is taking sudafed and benadryl, like 100 mg of Benadryl. She also experienced akathisia, She wanted to sleep really bad but then she started moving around, because she has had this with reglan or metoclopramide before. she is not taking any other drugs that could cause this, that was the only thing.
received lot number involved in the Recall; received lot number involved in the Recall; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a patient who received HBV (Engerix B) (batch number CP23D, expiry date 31st December 2023) for prophylaxis.   On an unknown date, the patient received Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The pediatric office receptionist reported that between 18th July and 25th August 2021, the patient received recall Engerix-B lot, which led to recalled drug administered and drug dispensing error. The reporter consented to follow up. This case was 1 of 20 linked cases, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021224975:same reporter
Per farther, pt fell bumping right knee and when picked up, pt arched her back stiffly, groaned, then went limp in forward slump for several moments. Pt regained normal wakeful behavior when parent thumped gently on the back. Pt experienced a similar episode later that same day. Two days later pt bumped her head, and experienced the same seizure type activity. Unable to take temperature.
Large local reaction with redness and swelling as well as blistering and serous oozing.
Narrative: Patient was admitted on 12/02/2022 for COVID pneumonia. Per H&P by inpatient provider, no hypoxia or noted respiratory distress per her exam.
night sweats; hot flashes during the day; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweats) and HOT FLUSH (hot flashes during the day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 012A21A) for COVID-19 vaccination.     Concurrent medical conditions included Menopause. Concomitant products included LEVOTHYROXINE, LIOTHYRONINE (NP THYROID), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) and COLLAGEN for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIGHT SWEATS (night sweats) and HOT FLUSH (hot flashes during the day). At the time of the report, NIGHT SWEATS (night sweats) and HOT FLUSH (hot flashes during the day) outcome was unknown.            Sees an Endocrinologist for her night sweats and hot flashes and has been post menopausal for 15 yrs. She has no thyroid. Prenatal multi vitamin was used as concomitant.  No treatment medications was provided.
Following Herpes Zoster Vaccine-had diminished hearing for about 3 months. Hearing gradually returned to normal.
9/7/2005 Evening of immunization felt weak.  When arose in AM was getting worse, cold sweat, dizziness, no energy, achiness, tingling in shoulders and neck. 9/8/2005 Left work. Presented to ER after vomiting and fever.  102 degree temp. at 3:30 PM at ER. 9/9/2005 Presented to our clinic with note of dx of hepatitis vaccination effect.  No further Hepatitis B vaccine to be given.
My arm was sore for a couple of days after receiving the vaccine. On 11/24/2022, I began not feeling well with a runny nose, sore throat and a headache. On 11/25/2022, I developed a cough and decided to take a COVID-19 home test and it was positive. I had a video appointment with a special nurse with my pharmacy on 11/26/2022 and I got a prescription for Paxlovid.  After taking Paxlovid for three days, I began feeling little lightheaded and my stomach felt queasy.
received her first dose on 03MAR2021 and 2nd dose is scheduled on 24MAR2021; This is a spontaneous report from a contactable consumer (behalf of her mother) from Pfizer sponsor program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via an unspecified route of administration on 03Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 03Mar2021 the patient received first dose and 2nd dose is scheduled on 24Mar2021 but tested Covid19 positive after the first dose on 15Mar2021. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
arm pain where I got the shot, we both have the symptoms; arm pain where I got the shot, we both have the symptoms; diarrhea; vomiting; stomach pains; He states his wife is very sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 64 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE:1, Manufacturer Unknown), for COVID-19 Immunization; Covid-19 vaccine (DOSE:2, Manufacturer Unknown), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "arm pain where I got the shot, we both have the symptoms"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; VOMITING (non-serious), outcome "unknown", described as "vomiting"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "stomach pains"; ILLNESS (non-serious), outcome "unknown", described as "He states his wife is very sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
6 month patient administrated with Kinrix; Kinrix was administrated instead of Pediarix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number 3ks4f, expiry date 22nd March 2024) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th October 2022, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 6th October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 06-OCT-2022 Reporter's Comment: The reporter was a medical assistant. The reporter reported that the 6 month old patient received Kinrix vaccine instead of Pediarix vaccine. The reporter did consent to follow up. Additional supportive information: The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration. The reporter reported that, they were intending to administered Pediarix and inadvertently administered Kinirix instead of Pediarix, which led to wrong vaccine administered. This is 1 of 4 cases reported by same reporter.; Sender's Comments:  US-GSK-US2022143282:Same reporter US-GSK-US2022143286:Same reporter US-GSK-US2022143285:Same reporter
On November 1st, patient reported to pharmacy that she had a burning and painful rash begin on her neck around her shirt collar on the night of October 31st. Despite the discomfort, she could not see any marks or redness at the time. On the morning of November 1st, she observed a rash after taking a hot shower. The rash was red with raised bumps that was warm to the touch. The rash was in the original place of discomfort (left side of front neck), as well as on the back of her neck (slightly on the left side). Both rashes were about 3-4 inches long and were burning and itchy. The patient had not done anything to relieve her discomfort at the time of this report. She had a scheduled doctor's visit on November 2nd and was advised to follow-up with her physician. She was advised to take an OTC pain reliever, use calamine lotion, take oatmeal baths, to wear loose clothing, and to use ice to relieve her discomfort in the meantime.
After all the vaccines were administered the patient started to have blurred vision and cold sweats, a few minutes after he faint. We monitor his pulse and call EMS. when paramedics arrived, patient was alert, and all vital signs were normal.
52 yr old female, AAOx4 with no prior medical conditions. RN followed up with the medical/nursing assessment. Patient did not have any S and S after the FLUMIST vaccine. Pt. was educated on the S and S and given VIS form of the vaccine provided. Pt was observed for 10 minutes and given instructions to call R.N. with any questions, and call 911 in case of an emergency. RN called to follow up with pt on 11/3/13. There was no answer and RN left message.
Fever to Tm 103 x >48 hours. ER visit at 24 hours of fever. MD visit at 48 hours of fever.
Patient cried non-stop since receiving PENTACEL. T=97.7. Patient was inconsolable until.
63 year old female received ZOSTAVAX 12/11/08 - reports slight headache about 4 hrs after increasedfatigue 12-24 hrs later dizzy, rapid heartbeat, shortness of breath, lightheaded about 24-36 hrs later. (L) arm swollen, localized rash, itchy (injection site)  (redness, painful) improving.
Injection given on 10-14-14 reaction of rash reported on 10-16-14. See attached.
Pfizer-BioNTech COVID-19 Vaccine EUA   Symptom onset was 2 weeks after second vaccine. Initially started with 48 hours of neck pain on the left side which then progressed to left sided facial drooping, inability to taste on front of tongue, decreased tear production in the left eye. Consistent with Bells Palsy. Started course of methylprednisolone today.  No improvement yet.
This solicited report received from the consumer and refers to a female patient in her teens as a part of a market research program. The patient's concurrent conditions, medical history, concomitant medications and past drugs were not reported. The reporter referred to the daughter (patient) of a parent in her church. On an unknown date in 2007 (approximately 9 years ago), when the patient was in her teens, she was vaccinated with GARDASIL. The patient's mother was reported to have gotten the patient vaccinated for HPV after finding out that the patient was sexually active. On an unspecified date, the patient had a bad reaction (details unspecified) to the vaccine (which made the reporter skeptical of the vaccine). After vaccination, the patient had an issue (details unspecified) 'that seemed to have been directly related that caused the doctors to think that she may be unable to bear children in the future' (female infertility). It was reported that patient had since had her first child (date unspecified). The outcome of event bad reaction to the vaccine was not reported. Action taken with the vaccine due to the events was not reported. The reporter considered infertility female to be related to GARDASIL. The causality of the event bad reaction to the vaccine with GARDASIL was not reported. Upon internal review, event infertility female was considered to be medically significant. Additional information is not expected since reporter not willing to contact further.
01/21/2022 Symptoms: MY at-home rapid came back Neg on 23rd. 01/24/2022 Positive result PCR @ Med Drive -up testing site. Mostly experienced sporadic sore throat, occasional sore throat, congestion, and fatigue. No fever. Spoke to Dr. by phone. He did not prescribe anything.
Vaccine actually drip down arm/ vaccinator had to wipe it off; not sure if she got the vaccine; sore arm; This is a spontaneous report from a contactable pharmacist. A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unknown route of administration on 15Jan2021 as a single dose for Covid-19 immunization. Medical history and concomitant medications were not reported. On 15Jan2021 the patient experienced " Vaccine actually dripped down arm and the vaccinator had to wipe it off; they are not sure if she actually got the vaccine or not" and experienced had a sore arm for a few day from an unknown date. The clinical outcome of the events incorrect dose administered and pain in extremity was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
103 degree temperature, severe body aches, lethargy, nausea, vomiting, diarrhea, dehydration, weakness, trembling, did not urinate for 24 hours.
Patient waited at clinic for 20 minutes after vaccine and left the clinic. Approximately 10 minutes after leaving the clinic, patient returned with reports of feeling flushed, light headed, and her face feeling hot. Patient placed in a clinic room in an upright position, with a cold rag on the back of her back. Injection site was noted to be without inflammation and irritation. Vital signs were B/P: 170/102, HR 88, R 18, Pulse Ox 99% ORA. Patient observed in the clinic for an additional 30 minutes. After that time patient reported that she was feeling better and no longer feeling flushed or light headed. Vitals signs at discharge were: B/P 140/82, P 82, R18, and Pulse Ox 99% ORA.
Persistent fevers (Tmax 102.3) for 3 days, severe fatigue, headaches. Day 2: swelling and pain in R axilla, R breast. Day 3: Right supraclavicular and R neck pain/lymphadenopathy also with skin reaction of red blotches on R upper anterior arm and R lateral breast
Initial report was received on 03/19/2006 and 05/23/06 from the patient. This is a 30 year old pregnant female with a history of asthma, seasonal allergies and one previous pregnancy that resulted in delivery of a normal, viable full term baby. The patient had received her last diphtheria tetanus vaccination some time in 1998 or 1999 (patient could not remember). She had been on progesterone fertility treatment for two weeks, between 04/17/2006 and 05/01/2006. The patient had received intramuscular dose of Adacel, lot number C2456AA, in the left deltoid muscle on 05/15/2006. The patient was not aware of the pregnancy at the time of the vaccination. Subsequent blood work confirmed the pregnancy. The expected date of delivery was reported as sometime in January or February 2007. The date of her last menstrual period was 04/14/2006. Forty eight hours post immunization, the patient developed soreness at the injection site. It was not reported if any treatment was received for this. At the time of this report, it was not reported if the patient had recovered from the injection site soreness.
After my 2nd Moderna shot on 3/26/2021, I got my period 12 days early the next day (on 3/27).
Adverse reaction: Heart palpitations; tightness in chest; difficulty breathing; lightheadedness from "attacks" with heavy breathing; shortness of breath when doing simple tasks and exhaustion. Treatment: No formal treatment prescribed other than rest. Outcome: Awaiting further testing for a formal diagnosis.